I agree that this site is using cookies. You can find further informations here.
X
Fudio, Salvador
30  results:
Search for persons X
?
1

Pharmacokinetics and Safety of Lurbinectedin Administrated ..:

Moreno, Irene ; Hernández, Tatiana ; Calvo, Emiliano...
Marine Drugs.  22 (2024)  4 - p. 178 , 2024
Link: https://doi.org/10.3390/..
 
?
2

Impact of a Moderate CYP3A4 Inducer (Bosentan) on Lurbinect..:

Moreno, Irene ; Hernández, Tatiana ; Calvo, Emiliano...
Pharmaceuticals.  17 (2024)  2 - p. 182 , 2024
Link: https://doi.org/10.3390/..
 
?
3

A model-based head-to-head comparison of single-agent lurbi..:

Fudio, Salvador ; Pérez-Ramos, Laura ; Asín-Prieto, Eduardo..
Frontiers in Oncology.  13 (2023)  - p. , 2023
Link: https://doi.org/10.3389/..
 
?
4

Quantitative determination of lurbinectedin, its unbound fr..:

King, Nicholas ; Garcia-Martinez, Soledad ; Alcaraz, Eider...
PLOS ONE.  18 (2023)  3 - p. e0283783 , 2023
Link: https://doi.org/10.1371/..
 
?
5

Anti-cancer drug combinations approved by US FDA from 2011 ..:

Fudio, Salvador ; Sellers, Alvaro ; Pérez Ramos, Laura...
Cancer Chemotherapy and Pharmacology.  90 (2022)  4 - p. 285-299 , 2022
Link: https://doi.org/10.1007/..
 
?
6

Phase I study of plitidepsin in combination with bortezomib..:

Mateos, María Victoria ; Prosper, Felipe ; Martin Sánchez, Jesús...
Cancer Medicine.  12 (2022)  4 - p. 3999-4009 , 2022
Link: https://doi.org/10.1002/..
 
?
7

Preclinical and randomized phase I studies of plitidepsin i..:

Varona, Jose F ; Landete, Pedro ; Lopez-Martin, Jose A...
Life Science Alliance.  5 (2022)  4 - p. e202101200 , 2022
Link: https://doi.org/10.26508..
 
?
8

Integrated exposure–response analysis of efficacy and safet..:

Fernández-Teruel, Carlos ; Fudio, Salvador ; Lubomirov, Rubin
Cancer Chemotherapy and Pharmacology.  89 (2021)  5 - p. 585-594 , 2021
Link: https://doi.org/10.1007/..
 
?
9

Population Pharmacokinetic‐Pharmacodynamic Modeling and Cov..:

Fernández‐Teruel, Carlos ; Lubomirov, Rubin ; Fudio, Salvador
The Journal of Clinical Pharmacology.  61 (2021)  9 - p. 1206-1219 , 2021
Link: https://doi.org/10.1002/..
 
?
10

A phase I trial of lurbinectedin in combination with cispla..:

Metaxas, Yannis ; Kahatt, Carmen ; Alfaro, Vicente...
Investigational New Drugs.  40 (2021)  1 - p. 91-98 , 2021
Link: https://doi.org/10.1007/..
 
?
11

Effect of lurbinectedin on the QTc interval in patients wit..:

Fudio, Salvador ; Tabernero, Josep ; Subbiah, Vivek...
Cancer Chemotherapy and Pharmacology.  87 (2020)  1 - p. 113-124 , 2020
Link: https://doi.org/10.1007/..
 
?
12

Population-Pharmacokinetic and Covariate Analysis of Lurbin..:

Fernandez-Teruel, Carlos ; Gonzalez, Ignacio ; Trocóniz, Iñaki F....
Clinical Pharmacokinetics.  58 (2018)  3 - p. 363-374 , 2018
Link: https://doi.org/10.1007/..
 
?
13

First-in-human phase I study of the microtubule inhibitor p..:

Elez, Elena ; Gomez-Roca, Carlos ; Soto Matos-Pita, Arturo...
Investigational New Drugs.  37 (2018)  4 - p. 674-683 , 2018
Link: https://doi.org/10.1007/..
 
?
14

Evaluation of the influence of sex and CYP2C19 and CYP2D6 p..:

Fudio, Salvador ; Borobia, Alberto M. ; Piñana, Enrique...
European Journal of Pharmacology.  626 (2010)  2-3 - p. 200-204 , 2010
Link: https://doi.org/10.1016/..
 
?
15

Preclinical and randomized phase I studies of plitidepsin i..:

Varona, Jose F ; Landete, Pedro ; Lopez-Martin, Jose A...
Life Science Alliance.  , 2022
Link: https://ddd.uab.cat/reco..
 
1-15